AAAAAA
Results:
1-15
|
Results: 15
Authors:
BASSON RP
GHOSH A
CERIMELE BJ
DESANTE KA
HOWEY DC
Citation: Rp. Basson et al., WHY RATE OF ABSORPTION INFERENCES IN SINGLE-DOSE BIOEQUIVALENCE STUDIES ARE OFTEN INAPPROPRIATE, Pharmaceutical research, 15(2), 1998, pp. 276-279
Authors:
MACIAS WL
BERGSTROM RF
CERIMELE BJ
KASSAHUN K
TATUM DE
CALLAGHAN JT
Citation: Wl. Macias et al., LACK OF EFFECT OF OLANZAPINE ON THE PHARMACOKINETICS OF A SINGLE AMINOPHYLLINE DOSE IN HEALTHY-MEN, Pharmacotherapy, 18(6), 1998, pp. 1237-1248
Authors:
CALLAGHAN JT
CERIMELE BJ
KASSAHUN KJ
NYHART EH
HOYESBEEHLER PJ
KONDRASKE GV
Citation: Jt. Callaghan et al., OLANZAPINE - INTERACTION STUDY WITH IMIPRAMINE, Journal of clinical pharmacology, 37(10), 1997, pp. 971-978
Authors:
CLORE J
WOODWORTH JR
CERIMELE BJ
BLACKARD WG
KURTZ D
Citation: J. Clore et al., MIXING INSULIN LISPRO (LP) WITH ULTRALENTE (U) INSULIN DOES NOT RESULT IN DECREASED OR DELAYED LP ABSORPTION, Diabetes, 46, 1997, pp. 579-579
Authors:
BERGSTROM RF
GOLDBERG MJ
CERIMELE BJ
HATCHER BL
Citation: Rf. Bergstrom et al., ASSESSMENT OF THE POTENTIAL FOR A PHARMACOKINETIC INTERACTION BETWEENFLUOXETINE AND TERFENADINE, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 643-651
Authors:
KURTZ DL
BERGSTROM RF
GOLDBERG MJ
CERIMELE BJ
Citation: Dl. Kurtz et al., THE EFFECT OF SERTRALINE ON THE PHARMACOKINETICS OF DESIPRAMINE AND IMIPRAMINE, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 145-156
Authors:
GOLDBERG MJ
BERGSTROM RF
CERIMELE BJ
THOMASSON HR
HATCHER BL
SIMCOX EA
Citation: Mj. Goldberg et al., FLUOXETINE EFFECTS ON PINDOLOL PHARMACOKINETICS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 51-51
Authors:
MAYA JF
CALLAGHAN JT
BERGSTROM RF
CERIMELE BJ
KASSAHUN K
NYHART EH
BRATER DC
Citation: Jf. Maya et al., OLANZAPINE AND WARFARIN DRUG-INTERACTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 67-67
Authors:
BASSON RP
CERIMELE BJ
DESANTE KA
HOWEY DC
Citation: Rp. Basson et al., TMAX - AN UNCONFOUNDED METRIC FOR RATE OF ABSORPTION IN SINGLE-DOSE BIOEQUIVALENCE STUDIES, Pharmaceutical research, 13(2), 1996, pp. 324-328
Authors:
MARDER P
SPAETHE SM
FROELICH LL
CERIMELE BJ
PETERSEN BH
TANNER T
LUCAS RA
Citation: P. Marder et al., INHIBITION OF EX-VIVO NEUTROPHIL ACTIVATION BY ORAL LY293111, A NOVELLEUKOTRIENE B-4 RECEPTOR ANTAGONIST, British journal of clinical pharmacology, 42(4), 1996, pp. 457-464
Authors:
RING BJ
CATLOW J
LINDSAY TJ
GILLESPIE T
ROSKOS LK
CERIMELE BJ
SWANSON SP
HAMMAN MA
WRIGHTON SA
Citation: Bj. Ring et al., IDENTIFICATION OF THE HUMAN CYTOCHROMES P450 RESPONSIBLE FOR THE IN-VITRO FORMATION OF THE MAJOR OXIDATIVE METABOLITES OF THE ANTIPSYCHOTICAGENT OLANZAPINE, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 658-666
Authors:
GOLDBERG MJ
COLLINS JF
ROWE HM
CERIMELE BJ
Citation: Mj. Goldberg et al., LOCAL AND SYSTEMIC PHENTOLAMINE ANTAGONISM OF NOREPINEPHRINE-INDUCED HAND VEIN CONSTRICTION, Journal of clinical pharmacology, 35(2), 1995, pp. 170-175
Authors:
SCHWARTZ SA
GOLDBERG MJ
GIDDA JS
CERIMELE BJ
Citation: Sa. Schwartz et al., EFFECT OF ZATOSETRON ON IPECAC-INDUCED EMESIS IN DOGS AND HEALTHY-MEN, Journal of clinical pharmacology, 34(3), 1994, pp. 250-254
Authors:
HAUG SP
BROWN DT
GOODACRE CJ
CERIMELE BJ
Citation: Sp. Haug et al., RECENT GRADUATES AND CURRENT DENTAL STUDENTS EVALUATION OF THEIR PROSTHODONTIC CURRICULUM, The Journal of prosthetic dentistry, 70(4), 1993, pp. 361-371
Authors:
THERASSE DG
FARLOW DS
DAVIDSON RL
QUADRACCI LJ
HATCHER BL
CERIMELE BJ
DESANTE KA
Citation: Dg. Therasse et al., EFFECTS OF RENAL DYSFUNCTION ON THE PHARMACOKINETICS OF LORACARBEF, Clinical pharmacology and therapeutics, 54(3), 1993, pp. 311-316
Risultati:
1-15
|